Showing results (1301-1310 of 5,347) with videos related to

Sort By:
Pageof 535
Japanese Journal of Clinical Oncology|July 26, 2026
Dose intensity and clinical outcomes across age groups in high-grade osteosarcoma treated with methotrexate, adriamycin, and cisplatin therapyBunpei Miyazaki, Yuki Kojima, Miho Nakajima, et al.
Japanese Journal of Clinical Oncology|August 7, 2026
Prognostic impact of regional lymph node metastasis at castration-resistant prostate cancer diagnosis on survival after radium-223 treatmentSaizo Fujimoto, Takuma Kato, Masatoshi Eto, et al.
Japanese Journal of Clinical Oncology|August 16, 2026
Extramedullary multiple myeloma simulating lymphoproliferative disease on multimodality imagingPaloma Salvador-Sáenz, Pablo A Álvarez-Reyes, Juan J Gómez-Herrera, et al.
Japanese Journal of Clinical Oncology|August 17, 2026
Long-term care needs and service use in terminally ill patients with cancer: a nationwide claims data studyRichi Takahashi, Takaaki Konishi, Yoko Nakazawa, et al.
Japanese Journal of Clinical Oncology|August 28, 2026
Enfortumab vedotin plus pembrolizumab for recurrent metastatic urothelial carcinoma following adjuvant nivolumabLan Inoki, Saizo Fujimoto, Mamoru Hashimoto, et al.
Japanese Journal of Clinical Oncology|August 28, 2026
Clinical features and treatment outcomes of fibrous dysplasia: a report from the Bone and Soft Tissue Tumor Registry in JapanMasayuki Morishita, Daisuke Kobayashi, Akira Ogose, et al.
Japanese Journal of Clinical Oncology|September 7, 2026
PDGFRA amplification could be a poor prognostic factor of advanced undifferentiated pleomorphic sarcoma in a comprehensive genomic profiling cohortHiroshi Kobayashi, Masachika Ikegami, Liuzhe Zhang, et al.
Japanese Journal of Clinical Oncology|September 21, 2026
The 2025 revision of JPOS/JASCC clinical guidelines for delirium in adult patients with cancer: a summary of recommendationsYoshinobu Matsuda, Jun Kako, Takaaki Hasegawa, et al.
Pageof 535